Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,361 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Active, Not Recruiting

Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation

NCT03953898

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Post Cytotoxic Therapy, +13 more
Locations
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Yale University New Haven, Connecticut, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
View Trial Details
Active, Not Recruiting

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

NCT00843882

Conditions
Anemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
View all 508 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

NCT02942290

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Duplicate_University of Arizona Cancer Center - North Campus /ID# 154155 Tucson, Arizona, United States
  • The University of Chicago Medical Center /ID# 153673 Chicago, Illinois, United States
  • University of Maryland, Baltimore /ID# 153669 Baltimore, Maryland, United States
  • Tufts Medical Center /ID# 153672 Boston, Massachusetts, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy

NCT05583552

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • Royal Adelaide Hospital Adelaide, Australia
  • Royal Brisbane and Women's Hospitals Brisbane, Australia
  • Linear Clinical Research Nedlands, Australia
  • CHU Nantes - Hôtel Dieu Nantes, France
View Trial Details
Active, Not Recruiting

AZD6738 for Patients With Progressive MDS or CMML

NCT03770429

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • BIDMC Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details

Related conditions